Back to Search
CHRISTY WHITLEY, PHARMD
PHARMD
Pharmacotherapy Pharmacist
NPI: 1588875496Individual
Specialties, Licenses & Credentials
Pharmacotherapy PharmacistPrimary
Pharmacist — Pharmacotherapy
Code: 1835P1200X
11058(NC)
Research & Publications (20)
The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York.
PMID 19346954·Genet Med·2009
8-other
Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study.
PMID 19261295·J Pediatr·2009
3-trial
Lysosomal Disease Network's "WORLD Symposium 2009". Introduction.
PMID 19083251·Mol Genet Metab·2009
8-other
Systemic correction of storage disease in MPS I NOD/SCID mice using the sleeping beauty transposon system.
PMID 19384290·Mol Ther·2009
7-preclinical
Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome.
PMID 18037941·Bone Marrow Transplant·2008
3-trial
Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase.
PMID 18502162·Mol Genet Metab·2008
3-trial
Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantation.
PMID 18278070·Bone Marrow Transplant·2008
8-other
Adoptively transferred dendritic cells restore primary cell-mediated inflammatory competence to acutely malnourished weanling mice.
PMID 18202192·Am J Pathol·2008
7-preclinical
Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study.
PMID 17693179·Lancet·2007
3-trial
Pre-stem cell transplantation enzyme replacement therapy in Hurler syndrome does not lead to significant antibody formation or delayed recovery of the endogenous enzyme post-transplant: a case report.
PMID 17631030·Pediatr Transplant·2007
5-case
Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon-mediated gene delivery: implications for non-viral gene therapy of mucopolysaccharidoses.
PMID 17407189·J Gene Med·2007
7-preclinical
Agalsidase-beta therapy for advanced Fabry disease: a randomized trial.
PMID 17179052·Ann Intern Med·2007
4-observational
Age-related functional and histopathological changes of the ear in the MPS I mouse.
PMID 17101178·Int J Pediatr Otorhinolaryngol·2007
7-preclinical
Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I.
PMID 16860035·Am J Cardiol·2006
2-rct
Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome.
PMID 15714083·Genet Med·2005
3-trial
Improved gene transfer and normalized enzyme levels in primitive hematopoietic progenitors from patients with mucopolysaccharidosis type I using a bioreactor.
PMID 15538732·J Gene Med·2004
8-other
Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene.
PMID 15194053·Mol Ther·2004
7-preclinical
Excision of Sleeping Beauty transposons: parameters and applications to gene therapy.
PMID 15133768·J Gene Med·2004
7-preclinical
Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).
PMID 15126989·J Pediatr·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 270 EASY ST
GREENVILLE, NC 27834 - Phone
- (252) 413-0063
Quick Facts
- NPI
- 1588875496
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile